Ads
related to: first line treatment for ibd- What Is Crohn's?
Learn About Crohn's Disease And
How To Help Relieve Your Symptoms.
- Treatment Options
Experiencing Crohn's Symptoms?
Learn About a Treatment Option.
- Set Treatment Goals
Help Reduce Your Symptoms
Talk To A Doctor Today.
- CD Treatment Goals
Use Our Interactive Tool To Learn
How To Reduce Inflammation.
- Register to Learn More
Sign Up to Receive Resources About
Crohn's & A Treatment Option.
- Treatment Video
Watch A Video About A Treatment
Option For Crohn's Disease.
- What Is Crohn's?
Search results
Results From The WOW.Com Content Network
The anti-TNF-α monoclonal antibody infliximab is a major biological therapy for inflammatory bowel disease. Biological therapy, the use of medications called biopharmaceuticals or biologics that are tailored to specifically target an immune or genetic mediator of disease, plays a major role in the treatment of inflammatory bowel disease. [1]
Azathioprine, shown here in tablet form, is a first line steroid-sparing immunosuppressant. Azathioprine and 6-mercaptopurine (6-MP) are the most commonly used immunosuppressants for maintenance therapy of Crohn's disease. They are purine anti-metabolites, meaning that they interfere with the synthesis of purines required for inflammatory cells.
Inflammatory bowel disease (IBD) is a group of inflammatory conditions of the colon and small intestine, with Crohn's disease and ulcerative colitis (UC) being the principal types. [3] Crohn's disease affects the small intestine and large intestine, as well as the mouth, esophagus, stomach and the anus, whereas UC primarily affects the colon ...
Because other conditions, such as pelvic inflammatory disease, ovarian cysts and inflammatory bowel disease (IBD) cause similar symptoms, the condition is difficult to diagnose.
First line treatment for collagenous colitis is the use of budesonide, a steroid that works locally in the colon and is highly cleared by first pass effect. Other medications that can be used include the following: [1] [6] Bismuth agents, including Pepto-Bismol; 5-aminosalicylic acid; Immunosuppressants, including azathioprine; Infliximab
Scientists believe a groundbreaking new test may predict patients at high risk of developing bowel cancer with 90 per cent accuracy. Research, published in the journal Gut on Thursday, could lead ...
Ad
related to: first line treatment for ibd